2care4 Generics ApS — Credit Rating and Financial Key Figures
CVR number: 36960566
Stenhuggervej 12, 6710 Esbjerg V
info@2care4generics.dk
tel: 76101500
www.2care4generics.dk
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -77.00 | 32 852.00 | 55 863.00 | 75 691.00 | 73 414.00 |
| Employee benefit expenses | -21 387.00 | -26 457.00 | |||
| Total depreciation | -9 655.00 | -5 797.00 | |||
| EBIT | -77.00 | 19 182.00 | 36 160.00 | 44 649.00 | 41 160.00 |
| Other financial income | 1 495.00 | 3 399.00 | |||
| Other financial expenses | -1 872.00 | -4 077.00 | |||
| Pre-tax profit | - 599.00 | 15 715.00 | 29 083.00 | 44 272.00 | 40 482.00 |
| Income taxes | -9 674.00 | -8 918.00 | |||
| Net earnings | - 599.00 | 15 715.00 | 29 083.00 | 34 598.00 | 31 564.00 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 33 846.00 | 34 547.00 | |||
| Intangible rights | 132.00 | 1 345.00 | |||
| Intangible assets total | 33 978.00 | 35 892.00 | |||
| Machinery and equipment | 575.00 | 513.00 | |||
| Tangible assets total | 575.00 | 513.00 | |||
| Other receivables | 35 417.00 | 72 433.00 | 127 774.00 | 77.00 | 84.00 |
| Investments total | 35 417.00 | 72 433.00 | 127 774.00 | 77.00 | 84.00 |
| Long term receivables total | |||||
| Finished products/goods | 24 168.00 | 45 564.00 | |||
| Advance payments | 7 693.00 | 2 274.00 | |||
| Inventories total | 31 861.00 | 47 838.00 | |||
| Current trade debtors | 24 034.00 | 21 723.00 | |||
| Current amounts owed by group member comp. | 62 415.00 | 62 686.00 | |||
| Current other receivables | 1 154.00 | 1 196.00 | |||
| Short term receivables total | 87 603.00 | 85 605.00 | |||
| Cash and bank deposits | 16 897.00 | 438.00 | |||
| Cash and cash equivalents | 16 897.00 | 438.00 | |||
| Balance sheet total (assets) | 35 417.00 | 72 433.00 | 127 774.00 | 170 991.00 | 170 370.00 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | - 166.00 | 15 549.00 | 44 632.00 | 50.00 | 50.00 |
| Shares repurchased | 19 250.00 | 25 000.00 | |||
| Other reserves | 26 400.00 | 26 946.00 | |||
| Retained earnings | 599.00 | -15 715.00 | -29 083.00 | -6 068.00 | 2 984.00 |
| Profit of the financial year | - 599.00 | 15 715.00 | 29 083.00 | 34 598.00 | 31 564.00 |
| Shareholders equity total | - 166.00 | 15 549.00 | 44 632.00 | 74 230.00 | 86 544.00 |
| Provisions | 8 663.00 | 8 670.00 | |||
| Non-current leasing loans | 356.00 | 350.00 | |||
| Non-current liabilities total | 356.00 | 350.00 | |||
| Current loans from credit institutions | 39 692.00 | 1 031.00 | |||
| Current trade creditors | 10 196.00 | 10 262.00 | |||
| Current owed to group member | 12 304.00 | 43 751.00 | |||
| Short-term deferred tax liabilities | 9 486.00 | 8 539.00 | |||
| Other non-interest bearing current liabilities | 16 064.00 | 11 223.00 | |||
| Current liabilities total | 87 742.00 | 74 806.00 | |||
| Balance sheet total (liabilities) | - 166.00 | 15 549.00 | 44 632.00 | 170 991.00 | 170 370.00 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.